Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results
08 avr. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Innovation Metals Corp. Provides Market Commentary on Recent Rare-Earth Industry Developments
22 févr. 2021 11h06 HE
|
Innovation Metals Corp.
TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to provide the following commentary on recent notable developments in the rare-earth elements...
DSG Global Enters Negotiations for US Manufacturing and Assembly Facilities for its Electric Vehicle Products
04 févr. 2021 11h41 HE
|
DSG Global Inc.
SURREY, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- DSG Global, Inc. (OTCQB: DSGT) ("DSGT" or the "Company") is in active negotiations for multiple US manufacturing and assembly facilities...
Innovation Metals Corp. Provides Development Update on RapidSX™ Technology for Near-Term Commercial Rare-Earth Elements Separation in USA
01 févr. 2021 11h08 HE
|
Innovation Metals Corp.
TORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to provide the following update regarding the Company’s ongoing commercialization development...
Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021 Virtual Conference
11 janv. 2021 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercialising oral...
Immuron SARS-CoV-2 Research Agreement with Monash University
15 déc. 2020 06h00 HE
|
Immuron Limited
Key Points Immuron’s Hyper-immune Bovine Colostrum, used to manufacture Travelan® and Protectyn®, demonstrated antiviral activity against the SARS-CoV-2/COVID-19 virus in laboratory studies.A New...
Immuron Receives AUD $358,280 R&D Tax Concession Refund
24 nov. 2020 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
US DoD Naval Medical Research Center Reports Positive Immunological Responses to Vaccine
11 nov. 2020 06h00 HE
|
Immuron Limited
Key Points NMRC demonstrated functional antibodies in new oral therapeutic targeting Campylobacter and ETECImmuron executes a Research Agreement with PCI Clinical Services to manufacture drug...
Fluidigm to Present at Upcoming Health Care Investor Conference
10 nov. 2020 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Innovation Metals Corp. Announces RapidSX™ Commercialization and Development Facility; Kingston Process Metallurgy Awarded Contract as RapidSX™ Laboratory Partner
23 juin 2020 14h08 HE
|
Innovation Metals Corp.
TORONTO, June 23, 2020 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to announce that the Company has executed a binding agreement with Kingston Process Metallurgy...